Patient preferences for the benefits and risks of insomnia medication in a clinical trial and real-world setting

A Beyer; Melissa Ross; Martin A. Katzman; Antonio Olivieri; Sebastian Heidenreich

doi:10.1186/s41606-025-00159-2

Affiliated Institutions

Related Publications

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis

Steven M. Opal , Charles J. Fisher , Jean-François Dhainaut +19 more

A 72-hr, continuous intravenous infusion of rhIL-1ra failed to demonstrate a statistically significant reduction in mortality when compared with standard therapy in this multice...

1997 Critical Care Medicine 850 citations

Sustainability of collaborative care interventions in primary care settings

Lawrence A. Palinkas , Kathleen Ell , Marissa C. Hansen +2 more

• Summary: We assessed patient and provider barriers and facilitators to sustainability of a collaborative depression care model for depression treatment in predominantly Hispan...

2010 Journal of Social Work 49 citations

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

Scott M. Grundy , James I. Cleeman , C. Noel Bairey Merz +6 more

The Adult Treatment Panel III (ATP III) of the National Cholesterol Education Program issued an evidence-based set of guidelines on cholesterol management in 2001. Since the pub...

2004 Circulation 6899 citations

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

Hisashi Saji , Morihito Okada , Masahiro Tsuboi +17 more

Lobectomy is the standard of care for early-stage non-small-cell lung cancer (NSCLC). The survival and clinical benefits of segmentectomy have not been investigated in a randomi...

2022 The Lancet 1432 citations

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Antiplatelet Trialists Collaboration

Aspirin (or another oral antiplatelet drug) is protective in most types of patient at increased risk of occlusive vascular events, including those with an acute myocardial infar...

2002 BMJ 6886 citations

Publication Info

Year: 2025
Type: article
Volume: 9
Issue: 1
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Patient preferences for the benefits and risks of insomnia medication in a clinical trial and real-world setting

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                
                                    A Beyer, 
                                
                                    Melissa Ross, 
                                
                                    Martin A. Katzman
                                
                                et al.
                            
                            (2025). 
                            Patient preferences for the benefits and risks of insomnia medication in a clinical trial and real-world setting. 
                            Sleep Science and Practice
                            , 9
                            (1)
                            .
                            https://doi.org/10.1186/s41606-025-00159-2
                        

Identifiers

DOI: 10.1186/s41606-025-00159-2